These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 61919)

  • 1. The influence of azathioprine on the behaviour of blood platelets in vitro.
    Bogdanikowa B; Myśliwiec M; Bielawiec M; Kiersnowska-Rogowska B
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1976; 103(2):248-51. PubMed ID: 61919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of azathioprine (Imuran) on the behavior of blood platelets in vitro].
    Bogdanikowa B; Myśliwiec M; Bielawiec M; Kiersnowska-Rogowska B
    Pol Tyg Lek; 1975 Sep; 30(36):1473-5. PubMed ID: 1161606
    [No Abstract]   [Full Text] [Related]  

  • 3. [Cyclic adenosine monophosphate, prostaglandin E and aggregation of blood platelets in man].
    Ardelt W
    Fortschr Med; 1977 Feb; 95(6):366-70. PubMed ID: 190100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular basis of the synergistic inhibition of platelet function by nitrovasodilators and activators of adenylate cyclase: inhibition of cyclic AMP breakdown by cyclic GMP.
    Maurice DH; Haslam RJ
    Mol Pharmacol; 1990 May; 37(5):671-81. PubMed ID: 2160060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of cytostatics on some platelet functions in vitro. VI. Vinblastine.
    Parízek M; Kubisz P
    Neoplasma; 1978; 25(5):625-9. PubMed ID: 740063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of cytotoxic drugs on platelet functions and coagulation in vitro. IV. Melphalan.
    Klener P; Kubisz P; Suranová J
    Thromb Haemost; 1977 Feb; 37(1):53-61. PubMed ID: 576517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of 1-(3-chloroanilino)-4-phenylphthalazine (MY-5445), a specific inhibitor of cyclic GMP phosphodiesterase, on human platelet aggregation.
    Hagiwara M; Endo T; Kanayama T; Hidaka H
    J Pharmacol Exp Ther; 1984 Feb; 228(2):467-71. PubMed ID: 6141286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of platelet aggregation by ethanol in vitro shows specificity for aggregating agent used and is influenced by platelet lipid composition.
    Fenn CG; Littleton JM
    Thromb Haemost; 1982 Aug; 48(1):49-53. PubMed ID: 6813995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Modification of the thrombocyte function using hormonal contraception. 1. Thrombocyte count, thrombocyte propagation and platelet aggregation under hormonal contraception].
    Traub RF; Brandt M; Hofmann KD
    Zentralbl Gynakol; 1976; 98(3):161-5. PubMed ID: 61668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of cis-platinum on some platelet functions in vitro.
    Kubisz P; Seghier F; Klener P; Holan J
    Neoplasma; 1983; 30(4):391-4. PubMed ID: 6684214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of platelet encapsulated Iloprost on platelet aggregation and adhesion to collagen and injured blood vessels in vitro.
    el-Gamal BA; Pfliegler G; Crawford N
    Thromb Haemost; 1992 Nov; 68(5):606-14. PubMed ID: 1280865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of adenosine and inosine administration on platelet function in rabbits.
    Singh J; Sudhir S; Gupta LC; Garg KN
    Indian J Physiol Pharmacol; 1990 Jan; 34(1):63-4. PubMed ID: 2163365
    [No Abstract]   [Full Text] [Related]  

  • 13. Cyclic 3',5'-adenosine monophosphate in human blood platelets. II. Effect of N6-2'-o-dibutyryl cyclic 3',5'-adenosine monophosphate on platelet function.
    Salzman EW; Levine L
    J Clin Invest; 1971 Jan; 50(1):131-41. PubMed ID: 4322665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 7-Bromo-1,5-dihydro-3,6-dimethylimidazo[2,1-b]quinazolin-2(3H)- one (Ro 15-2041), a potent antithrombotic agent that selectively inhibits platelet cyclic AMP-phosphodiesterase.
    Muggli R; Tschopp TB; Mittelholzer E; Baumgartner HR
    J Pharmacol Exp Ther; 1985 Oct; 235(1):212-9. PubMed ID: 2995647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-platelet effects of isocarbacyclin methyl ester on human and rabbit platelets in vitro.
    Inoue K; Aoki Y; Kitahara S; Kiyoki M; Araki H
    Arzneimittelforschung; 1995 Sep; 45(9):975-9. PubMed ID: 7488316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The inhibitory effect of GR32191, a thromboxane receptor blocking drug, on human platelet aggregation, adhesion and secretion.
    Hornby EJ; Foster MR; McCabe PJ; Stratton LE
    Thromb Haemost; 1989 Jun; 61(3):429-36. PubMed ID: 2529661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human-pharmacological investigations on the platelet adhesiveness- and aggregation-inhibiting effect of EMD 26 644, an oxazolyl-thio-propionic acid derivate.
    Jacobi E; Leopold G; Lissner R; Maisenbacher J
    Int J Clin Pharmacol Biopharm; 1978 Mar; 16(3):136-41. PubMed ID: 649232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adenylate cyclase activation determines the effect of thromboxane synthase inhibitors on platelet aggregation in vitro. Comparison of platelets from responders and nonresponders.
    Gresele P; Blockmans D; Deckmyn H; Vermylen J
    J Pharmacol Exp Ther; 1988 Jul; 246(1):301-7. PubMed ID: 3134542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of mitomycin C on platelet aggregation and adenosine 3',5'-monophosphate metabolism.
    Hashimoto S; Shibata S; Kobayashi B
    Thromb Haemost; 1978 Feb; 39(1):177-85. PubMed ID: 205972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pentoxifylline inhibits granulocyte and platelet function, including granulocyte priming by platelet activating factor.
    Hammerschmidt DE; Kotasek D; McCarthy T; Huh PW; Freyburger G; Vercellotti GM
    J Lab Clin Med; 1988 Aug; 112(2):254-63. PubMed ID: 2840477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.